These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22253463)

  • 41. Asymptomatic muscle metastasis from pulmonary adenocarcinoma.
    Banzo I; Martínez-Rodriguez I; Quirce R; Jimenez-Bonilla J; Carril JM
    Thorax; 2011 Jul; 66(7):642. PubMed ID: 21307150
    [No Abstract]   [Full Text] [Related]  

  • 42. Anthracotic solitary pulmonary nodule imitating lung malignancy on F-18 FDG PET/CT imaging.
    Canbaz F; Kefeli M; Sahin Z; Basoglu T
    Clin Nucl Med; 2011 Oct; 36(10):955-6. PubMed ID: 21892061
    [No Abstract]   [Full Text] [Related]  

  • 43. [18F]Fluorodeoxyglucose PET in Thoracic Malignancies.
    Vilstrup MH; Torigian DA
    PET Clin; 2014 Oct; 9(4):391-420, v. PubMed ID: 26050944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
    Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
    Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. (18)FDG-PET-scan in staging of primary malignant melanoma of the oesophagus: a case report.
    Vandewoude M; Cornelis A; Wyndaele D; Brussaard C; Kums R
    Acta Gastroenterol Belg; 2006; 69(1):12-4. PubMed ID: 16673556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Value of positron emission tomography in diagnosing synchronous penile metastasis from urothelial bladder cancer.
    Rouanne M; Alhammadi A; Vilain D; Radulescu C; Lebret T
    World J Surg Oncol; 2015 Sep; 13():276. PubMed ID: 26376852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synchronous ovarian carcinoma detected on staging ¹⁸F-FDG PET/CT in a patient of esophageal carcinoma: a rare association.
    Mukherjee A; Sharma P; Karunanithi S; Jain S; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2014; 33(5):308-9. PubMed ID: 25017383
    [No Abstract]   [Full Text] [Related]  

  • 48. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Bifocal lung cancer: the same histology?].
    Rivière F; Bonnichon-Py A; Le Floch H; Staub E; Mairovitz A; Salles Y; Margery J; Saint-Blancard P; Pons F; Foehrenbach H; Marotel C; Vaylet F
    Rev Pneumol Clin; 2011 Apr; 67(2):113-7. PubMed ID: 21497727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data.
    Barber TW; Duong CP; Leong T; Bressel M; Drummond EG; Hicks RJ
    J Nucl Med; 2012 Jun; 53(6):864-71. PubMed ID: 22582047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET).
    Kut V; Spies W; Spies S; Gooding W; Argiris A
    Am J Clin Oncol; 2007 Feb; 30(1):45-50. PubMed ID: 17278894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PET/CT in non-small cell lung cancer staging-promises and problems.
    Devaraj A; Cook GJ; Hansell DM
    Clin Radiol; 2007 Feb; 62(2):97-108. PubMed ID: 17207691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. False positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography liver lesion mimicking metastasis in 2 patients with gastroesophageal cancer.
    Paudel N; Kunz PL; Poultsides GA; Koong AC; Chang DT
    Pract Radiat Oncol; 2014; 4(6):368-71. PubMed ID: 25407856
    [No Abstract]   [Full Text] [Related]  

  • 54. Early metabolic response on 18F-fluorodeoxyglucose-positron-emission tomography/computed tomography after concurrent chemoradiotherapy for advanced stage III non-small cell lung cancer is correlated with local tumor control and survival.
    Jeong JU; Chung WK; Nam TK; Song JY; Yoon MS; Kim YC; Kim KS; Oh IJ; Ban HJ; Kwon SY; Bom HS; Ahn SJ
    Anticancer Res; 2014 May; 34(5):2517-23. PubMed ID: 24778069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The diagnosis of esophageal cancer by 2-deoxy-2-F-18 fluoro-D-glucose positron emission tomography (F-18 FDG PET).
    Alexander M; Brasić JR
    Clin Nucl Med; 2006 Sep; 31(9):566-7. PubMed ID: 16921288
    [No Abstract]   [Full Text] [Related]  

  • 56. [Not Available].
    Hamerla G; Meyer HJ; Purz S; Surov A
    Rofo; 2018 Oct; 190(10):971-972. PubMed ID: 29665589
    [No Abstract]   [Full Text] [Related]  

  • 57. Is there a role for positron emission tomography/computed tomography in the staging of small-cell lung cancer?
    Truong MT; Marom EM
    Clin Lung Cancer; 2008 Jan; 9(1):8. PubMed ID: 18282351
    [No Abstract]   [Full Text] [Related]  

  • 58. 18F-2-Deoxy-d-Glucose positron emission tomography-computed tomography in lung cancer.
    Delappe E; Dunphy M
    Semin Roentgenol; 2011 Jul; 46(3):208-23. PubMed ID: 21726705
    [No Abstract]   [Full Text] [Related]  

  • 59. [Non small cell lung carcinoma - evaluation of tumor heterogeneity using CT texture analysis].
    Manych M
    Rofo; 2012 Nov; 184(11):978. PubMed ID: 23104480
    [No Abstract]   [Full Text] [Related]  

  • 60. Lung cancer.
    Akhurst T; MacManus M; Hicks RJ
    PET Clin; 2015 Apr; 10(2):147-58. PubMed ID: 25829084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.